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Summary 
High-throughput molecular technologies have greatly enhanced our 
understanding of biological processes by characterizing expression changes of 
genes (microarray and RNA-Seq data) and proteins (proteomics data), or 
transcription factor targets and epigenetics states (ChIP-chip and ChIP-Seq 
data). Among them, transcriptome studies based on microarrays or RNA-Seq 
have the ability to identify genes involved in the response to environmental 
change or specific stressors, thereby helping us to infer the underlying 
biological processes.  
During my PhD, I mainly focused on transcriptomic data analysis, using in most 
cases the nematode Caenorhabditis elegans as a model taxon. In particular, I 
have addressed seven specific projects: i) development of ABSSeq, an 
improved detection approach of differential gene expression for RNA-Seq data; 
ii) development of aFold, a method to fully moderate fold-change of RNA-Seq 
data and to improve gene ranking and visualization; iii) development of 
WormExp, a knowledge-based approach for interpreting gene sets in C. 
elegans; iv) exploration of the regulation of the C. elegans immune system 
using curated data sets from WormExp; v) characterization of putative major 
effectors (GATA transcription factors) in the C. elegans innate immune system; 
vi) comparison of the immune response of C. elegans at protein and transcript 
level.  
In general, our work facilitates high-throughput data analysis via improving 
pattern inference and interpretation, which in practice provides new insights into 
the immune system of C. elegans. 
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Zusammenfassung 
Die Charakterisierung der Expressionsänderungen von Genen (Microarray- 
und RNA-Seq-Daten) und Proteinen (Proteomikdaten) oder 
Transkriptionsfaktor-Targets und epigenetischen Zuständen (ChIP-Chip und 
ChIP-Seq-Daten) mittels molekularer Hochdurchsatztechnologien hat unser 
Verständnis von biologischen Prozessen maßgeblich verbessert. Unter diesen 
haben Transkriptomstudien, die auf Microarrays oder RNA-Seq basieren, die 
Fähigkeit, Gene zu identifizieren, die an der Reaktion auf 
Umweltveränderungen oder spezifische Stressoren beteiligt sind. Dies hilft, auf 
die zugrundeliegenden biologischen Prozesse schließen zu können. 
Während meiner Promotion konzentrierte ich mich vor allem auf die 
transkriptomische Datenanalyse, wobei in den meisten Fällen der Nematode 
Caenorhabditis elegans als Modell verwendet wurde. Im Speziellen behandelte 
ich dabei sieben spezifische Projekte: i) Entwicklung von ABSSeq, einem 
verbesserten Erkennungsansatz der differentiellen Genexpression für RNA-
Seq-Daten; ii) Entwicklung von aFold, einer Methode zur vollständigen 
Normierung des Fold Change von RNA-Seq-Daten und zur Verbesserung des 
Gen-Rankings und der Visualisierung; iii) Entwicklung von WormExp, einem 
wissensbasierten Ansatz zur Interpretation von C. elegans-Gensätzen; iv) 
Erforschung der Regulation des C. elegans-Immunsystems unter Verwendung 
von kuratierten Datensätzen von WormExp; v) Charakterisierung von 
potentiellen Haupteffektoren (GATA-Transkriptionsfaktoren) im angeborenen 
Immunsystem von C. elegans; vi) Vergleich der Immunantwort von C. elegans 
auf Protein- und Transkriptebene. 
Zusammenfassend erleichtert unsere Arbeit die Hochdurchsatzdatenanalyse 
durch die Verbesserung der Musterinferenz und -interpretation, die in der Praxis 
neue Einblicke in das Immunsystem in C. elegans liefert. 
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Introduction 
Pattern inference and interpretation are the major interests for omics studies, 
which have greatly enhanced our understanding of biological processes. My 
PhD project focused on transcriptome data analysis in the well-established 
model organism C. elegans, which relies on identifying differentially expressed 
genes (pattern inference) between different conditions, as well as inferring their 
potential biological functions (pattern interpretation). In the present work I 
developed new approaches to detect differential expression (DE) in RNA-Seq 
datasets and specifically infer underlying biological functions in C. elegans. 
With the help of these new approaches, we addressed the regulation effectors 
of C. elegans innate immune responses. This introduction provides information 
necessary to understand the present work and includes four major topics: C. 
elegans as a model organism and its immunity system, omics studies in C. 
elegans, DE detection of RNA-Seq data and biological function inference on 
DE. 
1 C. elegans – an invertebrate model organism for innate immunity 
research 
The innate immune system serves as the first line to defend animals and plants 
against pathogenic infections. It shares common features in molecular 
pathways across vertebrates and invertebrates, such as flies, nematodes and 
mammals [1]. Because of these evolutionary conserved characteristics, the 
study of invertebrate host defenses can provide a better understanding of 
vertebrate innate immunity, including those of relevance for humans. The 
nematode C. elegans, with its completely sequenced genome, genetic 
tractability, and susceptibility to a number of human and other animal pathogens; 
is widely used as a powerful invertebrate model organism to study innate 
immunity [2, 3]. 
1.1 Known effectors in C. elegans immune system 
Previous studies revealed that this nematode’s immune system relies on 
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several signaling pathways conserved across invertebrates and vertebrates 
including: the p38 mitogen-activated protein kinase (MAPK), c-Jun N-terminal 
kinase (JNK) MAPK, extracellular signal-regulated kinase (ERK) MAPK, 
transforming growth factor-β (TGF-β), and also the insulin-like receptor (ILR) 
pathways [4-6]. Several transcription factors have been identified to contribute 
to C. elegans immune defense, such as: the GATA transcription factor ELT-2 
[7], the basic-region leucine zipper (bZIP) transcription factors ATF-7 [8], ATFS-
1 [9], ZIP-2 [10], and SKN-1 [11], the basic helix-loop-helix (bHLH) transcription 
factor HLH-30 [12], the signal transducer and activator of transcription (STAT)-
like transcription factor STA-2 [13], and the activator protein 1 (AP-1) 
transcription factor dimer JUN-1/FOS-1 [14]. Moreover, pathogen elimination 
involves certain antimicrobial effectors [15], including for example the 
caenacins and related peptides [16], the caenopores [17, 18], and additionally 
the generation of reactive oxygen species (ROS) [19, 20]. While it remains 
unclear if and how pathogens are directly recognized by C. elegans, nematode 
defense can also be activated indirectly through a cellular surveillance system 
and/or damage signals, allowing the worms to respond to the cellular 
disturbance caused by an infection [21-23]. 
2 Omics and their application on C. elegans research 
High-throughput molecular technologies have greatly enhanced our 
understanding of biological processes by characterizing expression changes of 
genes (microarray and RNA-Seq data) and proteins (proteomics data) or 
transcription factor targets and epigenetic states (ChIP-chip and ChIP-Seq 
data). 
Although most studies on C. elegans rely on functional genetic approaches, 
numerous transcriptomic and proteomic analyses have additionally been 
performed to explore the sets of genes, which are activated or repressed upon 
specific conditions or life stages. Over the last decade, more than 350 high-
throughput expression studies have been published, covering a large variety of 
research themes, such as immunity, aging, development, and stress responses. 
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The resulting lists of differentially expressed genes are publicly available and 
can be related to a specific experimental design, environmental condition, 
and/or gene defect. Because they capture a variety of inducible expression 
responses of this particular organism, they might be highly useful in interpreting 
new C. elegans gene lists [24, 25] or predicting candidates for downstream 
analysis [26]. 
However, omics studies usually yield hundreds or thousands of differentially 
regulated genes or proteins that are not always easy to interpret. Validation of 
the numerous differentially expressed genes is usually not possible. Uncovering 
the underlying organizational principles from such large gene lists requires 
computational and statistical approaches as well as precise biological reference 
information. 
2.1 Omics on C. elegans immunity 
Currently, gene or protein expression change in C. elegans upon exposure to 
21 pathogens (including gram-positive and negative bacteria, fungi and virus) 
and six non-pathogenic bacterial strains have been quantified. Several of these 
studies involved more than one pathogen and showed an overlapping signature 
in the response to the various pathogens [6, 27], indicating the presence of a 
common regulatory mechanism in the worm's immune system. 
3 RNA-Seq and differential expression inference 
3.1 RNA-Seq 
RNA Sequencing or RNA-Seq is a recent and popular technology for 
transcriptome studies, which is based on next generation sequencing. In 
contrast to array-based approaches, RNA-Seq could quantify genome-wide 
gene expression without genome annotation and thus is widely used to study 
both model and non-model organisms [28]. The underlying aim of transcriptome 
or RNA-Seq studies is to understand inducible biological functions through an 
analysis of differential gene expression (DE), which is usually inferred from 
comparison of two different treatments, life stages or tissues, among other 
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conditions that can be compared. 
Read count of RNA-Seq data requires normalization before DE inference in 
order to reduce possible biases from variation in sequencing depth, library 
preparation, sequencing in different lanes or other random factors [29, 30]. 
3.2 Differential expression analysis on RNA-Seq 
Current statistical approaches for DE analysis in RNA-Seq rely on fitting the 
distribution of read counts with probabilistic models [31-35]. These methods 
usually detect DE via false discovery rate (FDR) adjusted p-value, which highly 
depends on mean-variance relationship [31, 36, 37]. However, variance could 
be arbitrarily small or even zero (under-estimated) even after borrowing 
information from other genes, which often results in highly statistically 
significant DE [38, 39] as well as high type I error rate and FDR, but with 
extremely small fold-change [40-42]. There is therefore often a clear-cut 
inconsistency between the statistical result and the preferred cut-off value in 
practice. Efficiently reducing such potential artifacts requires additional cutoffs 
in fold change [40-42], which somehow agrees with the interests of biologists 
in term of worthwhile change, for instance a fold change of at least 1.5 or 2.0 
[43-45]. Moreover, false positives of DE are also commonly present in genes 
with high coefficient of variation (usually at low expression level), therefore a 
third cutoff of expression value seems also necessary [40-42]. Even though 
these sources of problems in DE estimation are clear, there is still the need to 
develop strategies to avoid introducing the new problem of an arbitrary choice 
of the fold-change cut-off and expression value cut-off.  
4. Gene set enrichment analysis – inferring biological function 
Gene set enrichment analysis represents a powerful tool to link the identified 
differentially expressed gene lists to biological processes and functions. They 
are based on the statistical evaluation of the overlap between the generated 
gene set and a specified reference list of genes. These enrichment analyses 
are usually based on public databases such as those defined by Gene Ontology 
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[46] and KEGG pathways [47]. However, these existing databases have 
important drawbacks. First, the annotations are incomplete and only a subset 
of known genes are functionally annotated [48]. For example, functional 
information is only available for approximately 60% of the gene repertoire of the 
nematode C. elegans [49]. Second, the included functional information is often 
imprecise, as it usually represents an extrapolation from experimental data of 
a different taxon and thus assumes a high level of functional conservation 
across evolution, which may not always be the case [50]. Third, functional 
information is predicted for most organisms from protein domains. Taxon-
specific genes or protein domains may thus be missed. Taxon-specific gene 
sets, which explicitly consider taxon-restricted genes and also taxon-specific 
expression responses, are thus required for improved functional genomic 
analyses. Several applications such as GSEA [51] and EASE [52] have been 
developed to permit performance of enrichment analyses with curated gene 
sets, derived for example from published expression studies in the same 
organism. Yet, a systematic assessment of the value of taxon-specific 
enrichment analyses is still missing. 
In general, omics studies produce numerous data that retains noise and thus 
requires efficient statistical tools to explore the underlying biological signatures 
and functions. During the PhD period, I developed approaches to improve DE 
detection of RNA-Seq and biological function inference upon DE, which has 
been applied on the study of C. elegans immunity system. This thesis 
summarizes these works in seven Chapters. 
 
PhD Thesis Content 
The aim of the PhD project was to improve pattern inference and interpretation 
for omics study. The current PhD thesis embraces three aspects: i) pattern 
inference (DE detection); ii) pattern interpretation (gene set enrichment 
analysis); iii) their application on C. elegans immune response. I use seven 
chapters to describe and discuss these three aspects.  
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Chapter I represents a published approach for DE detection on RNA-Seq data 
with title “ABSSeq: a new RNA-Seq analysis method based on modelling 
absolute expression differences”. Here we introduce a new analysis approach, 
ABSSeq, which uses a negative binomal distribution to model absolute 
expression differences between conditions, taking into account variations 
across genes and samples as well as magnitude of differences. In comparison 
to alternative methods, ABSSeq shows higher performance on controlling type 
I error rate and at least a similar ability to correctly identify differentially 
expressed genes. This chapter refers to pattern inference. 
Chapter II is a manuscript that is ready for submission. Here, we introduce a 
new approach, aFold (i.e., accurately estimation of fold change from RNA-Seq 
data), which provides a statistical framework to solve the problem of an arbitrary 
choice of cut-off values by integrating all sources of variation into fold change 
calculation. This approach models the uncertainty of read count via a 
polynomial function of sample mean and standard deviation. aFold also provide 
an efficient strategy for determining cutoff of fold change across all significant 
levels. Instead of modelling read count distribution, aFold employs a zero-
centered normal distribution on testing shifted log fold changes against a global 
standard deviation, which therefore avoid the influence of extremely small 
variance. This chapter refers to pattern inference. 
Chapter III is a published approach for gene set enrichment analysis 
specifically on C. elegan with title “WormExp: a web-based application for a 
Caenorhabditis elegans-specific gene expression enrichment analysis”. We 
here present a web-based application for a taxon-specific gene set exploration 
and enrichment analysis, which is expected to yield novel functional insights 
into newly determined gene sets. The approach is based on the complete 
collection of curated high-throughput gene expression data sets for the model 
nematode C. elegans, including 1980 gene sets from more than 350 studies. 
This chapter refers to pattern interpretation. 
Chapter IV is a published study on C. elegans immune response to Bacillus 
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thuringiensis with title “Overlapping and unique signatures in the proteomic and 
transcriptomic responses of the nematode Caenorhabditis elegans towards 
pathogenic Bacillus thuringiensis”. Here, we compare transcriptome and 
proteome data generated after infection of the nematode and model organism 
C. elegans with the Gram-positive pathogen B. thuringiensis. Our analysis 
revealed a high overlap between abundance changes of corresponding 
transcripts and gene products, especially for genes encoding C-type lectin 
domain-containing proteins, indicating their particular role in worm immunity. 
We additionally identified a unique signature at the proteome level, suggesting 
that the C. elegans response to infection is shaped by changes beyond 
transcription. Such effects appear to be influenced by AMP-activated protein 
kinases (AMPKs), which may thus represent previously unknown regulators of 
C. elegans immune defense. This chapter refers to application of pattern 
inference and interpretation. 
Chapter V is a published study on C. elegans immune response to B. 
thuringiensis and Pseudomonas aeruginosa. with title “Contrasting invertebrate 
immune defense behaviors caused by a single gene, the Caenorhabditis 
elegans neuropeptide receptor gene npr-1”. Here, we demonstrate in the model 
invertebrate C. elegans that a single gene, a homolog of the mammalian 
neuropeptide Y receptor gene, npr-1, mediates contrasting defense phenotypes 
towards two distinct pathogens, the Gram-positive B. thuringiensis and the 
Gram-negative P. aeruginosa. Subsequent transcriptional profiling of C. 
elegans wildtype and npr-1 mutant suggested that npr-1 mediates defense 
against both pathogens through p38 MAPK signaling, insulin-like signaling, and 
C-type lectins. Importantly, increased defense towards P. aeruginosa seems to 
be additionally influenced through the induction of oxidative stress genes and 
activation of GATA transcription factors, while the repression of oxidative stress 
genes combined with activation of Ebox transcription factors appears to 
enhance susceptibility to B. thuringiensis. This chapter refers to application of 
pattern inference and interpretation. 
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Chapter VI is a published study of meta-analysis on C. elegans immunity 
system with title “GATA transcription factor as a likely key regulator of the C. 
elegans innate immune response against gut pathogens”. In this study, we take 
advantage of WormExp in order to explore commonalities and differences in 
the regulation of nematode immune defense against a large variety of 
pathogens versus food microbes. We identified significant overlaps in the 
transcriptional response towards microbes, especially pathogenic bacteria. We 
also found that the GATA motif is overrepresented in many microbe-induced 
gene sets and in targets of other previously identified regulators of worm 
immunity. This chapter refers to application of pattern inference and 
interpretation. 
Chapter VII is a review on C. elegans immunity system with title “Antimicrobial 
effectors in the nematode C. elegans – an outgroup to the Arthropoda”. In this 
review, we discuss putative C. elegans antimicrobial effector proteins, such as 
lysozymes, caenopores (or saposin-like proteins), defensin-like peptides, 
caenacins and neuropeptide-like proteins, in addition to the production of 
reactive oxygen species and autophagy. We provide an overview of C. elegans 
immune effector proteins and mechanisms. We summarize the experimental 
evidence of their antimicrobial function and involvement in the response to 
pathogen infection. We further evaluate the microbe-induced expression of 
effector genes using WormExp (Chapter III). We emphasize the need for further 
analysis at the protein level to demonstrate an antimicrobial activity of these 
molecules both in vitro and in vivo. This chapter refers to application of pattern 
inference and interpretation. 
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Abstract 
Identification of significant differential expression represents a crucial initial step 
in RNA-Seq analysis. Here, we introduce two procedures to enhance 
assessment of differential gene expression: a normalization method, qtotal, 
based on the overall distribution of read count, and an analysis approach, aFold, 
to calculate fold change and significance of differential expression. aFold uses 
a polynomial function to model the uncertainty (or variance) of read count, and 
thus takes into consideration the variance of expression levels across 
treatments and genes. In comparison to alternative methods, aFold shows at 
least a similar ability to correctly identify differentially expressed genes. The 
inferred fold change values are comparable across experiments and might thus 
facilitate data clustering, visualization, and other downstream applications. We 
conclude that aFold represents a highly efficient new approach for fold change 
estimation and identification of significant differential expression across distinct 
data distributions..  
 
 
 
 
 
 
 
 
 
Keywords 
RNA-Seq, Transcriptome analysis, Differential gene expression, ABSSeq, 
aFold 
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Background 
RNA Sequencing or RNA-Seq has become a popular approach for the analysis 
of gene expression variation and uses the enormous recent advances in next 
generation sequencing technology. In contrast to array-based methods, RNA-
Seq permits the quantification of gene expression without detailed prior genome 
information, such as gene annotations. Thus it is widely used for both classical 
model organisms and also non-model taxa [1]. The most common aim of such 
RNA-Seq studies is to understand inducible biological functions, usually 
through the analysis of differential gene expression (DE), based on comparison 
of gene expression levels between two different biological states, as defined by 
exprimental treatments, developmental stages, or different tissues. 
Current statistical approaches for DE analysis in RNA-Seq rely on fitting the 
distribution of read counts with probabilistic models [2-6]. These methods 
usually detect significant DE via an inferred probability value, usually adjusted 
for multiple testing with the false discovery rate (FDR), a procedure, which 
highly depends on mean-variance relationships [2, 7, 8]. However, the available 
variance can be arbitrarily small or even zero (indicating under-estimation), 
even after employing models that adjust individual variance levels according to 
mean-variance relationships across genes. Such small variance may result in 
highly statistically significant DE [9, 10] yet also high type I error and FDR at 
extremely small fold-change [11-13]. To reduce the number of resulting artifacts, 
additional cut-offs in fold change are commonly used [11-13] and often explicitly 
warranted, in order to be able to focus on only large changes for subsequent 
downstream analysis. Commonly used thresholds are a fold change of at least 
1.5 or 2.0 [14-16]. Moreover, as false positives of DE are also frequently found 
for genes with a high coefficient of variation, usually at low expression levels, 
another cut-off for a minimum expression value or read count is also widely 
applied [11-13]. Both strategies are not ideal, because they rely on an arbitrary 
choice of the applied threshold for either minimum fold-change and/or minimum 
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expression value.  
Alternative solutions are based on the idea of merging these cut-offs into a 
single statistical model or by reducing the effect of high coefficients of variation. 
For example, TREAT for t-test in microarray data partially addresses this 
problem via testing the significance of DE on a given fold-change threshold [14]. 
DESeq2 utilizes empirical Bayes method to shrink log fold changes toward zero 
in consideration of read count dispersion [7]. GFOLD generalizes fold changes 
based on the posterior distribution of log fold change for RNA-Seq data without 
replicates [9]. However, these methods only provide a partial solution to the 
problem. The approach in TREAT still requires that the user provides a cut-off 
value for fold change. The DESeq2 approach identifies significant DE via a 
Wald-test comparison of the standard error of log fold change estimates with a 
normal distribution, which might still result in false positives with extremely small 
fold-changes [11-13]. The GFOLD method can only be used for data without 
replication. 
Here, we introduce a new approach, aFold (i.e., accurate estimation of fold 
change from RNA-Seq data), which provides a statistical framework to address 
the problem of an arbitrary choice of cut-off values by integrating different 
sources of variation into the calculation of fold-change values. The observed 
read counts of RNA-Seq data are characterized by several levels of uncertainty 
(resulting in observed variance) as a consequence of biological variation, but 
also due to systematic or non-systematic biases during libarary preparation and 
sequencing [12, 17]. Our approach tries to avoid the implicit assumption of a 
specific distribution of the read count data (e.g., Poisson or negative binomial, 
NB [8]). Instead, we explicitly model the uncertainty in the read count data via 
a polynomial function of the sample mean and standard deviation. aFold takes 
into account two sources of variance for fold change calculations: 1) the 
observed variance in gene expression (read count variation across replicates); 
and 2) the hidden or unknown variance due to limited sample size, which is 
accommodated via fitting the mean-variance relationship (borrowing 
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information from genes). aFold additionally penalizes high uncertainty of 
variance estimates, thus ensuring comparability of fold changes across genes 
and treatments. 
In addition to estimating fold change itself, aFold also provides an efficient 
strategy for determining fold change cut-off values for different significance 
levels, thus yielding a statistical test of DE. To achieve this, aFold does not 
directly model read count distributions. Instead, it employs a zero-centered 
normal distribution on estimated log fold changes and compares them with the 
global standard deviation, which avoids the influence of extremely small 
variances on significance inference. Moreover, we also introduce a new 
procedure to improve the normalization of RNA-Seq samples under DE, which 
represents a key problem in transcriptomic studies [10, 18]. Using real and 
simulated datasets, we demonstrate that aFold is more efficient in DE ranking, 
DE visualization, and FDR reduction than the two currently most popular RNA-
Seq analysis approaches, DESeq2 [7] and limma [19, 20]. For our analysis, we 
specifically focused on these two alternatives, but did not consider other 
methods such edgeR, DESeq and baySeq, beause these were previously 
shown by colleagues or us to perform worse than DESeq2 and Voom when 
tested with the same data sets [7, 20, 21].  
 
RESULTS and DISCUSSION 
We firstly introduce a new normalization procedure, qtotal, which we 
implemented in the aFold package and which aims at standardizing reads count 
variation by accommodating the influence of DE on the total number of reads 
count. Thereafter, we illustrate the aFold approach to model fold change and 
assess its statistical significance with the help of the HapMap-CEU data set. 
Thereafter, performance of aFold is compared with that of DESeq2 and Voom, 
always used under default settings (see Additional file 1). These two methods 
also consider log fold change for DE inference and report moderated (DESeq2) 
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or raw (Voom) fold changes as output. Method performance is evaluated based 
on three complementary criteria: 1) correct gene ranking, that is the ability to 
rank truly DE genes ahead of non-DE genes; 2) minimization of errors, in 
particular FDR and type I error rate; and 3) visualization of reported fold 
changes. We use different well-studied real data sets to assess the 
performance of each method (Table 1). In addition, we also use simulated data  
in method evaluation, for which data structure can be efficiently controlled and 
which have been widely used to evaluate similar DE analysis methods [3, 10, 
13, 22-25].  
 
qtotal normalization of reads count data 
Reads count of RNA-Seq data requires normalization before DE inference in 
order to reduce possible biases from variation in sequencing depth, library 
preparation, sequencing in different lanes, or other random factors [18, 26]. A 
variety of different normalization procedures have been developed, which 
adjust individual reads count values across replicates and treatments to 
achieve a standardization of: 1) total number of reads count (a procedure 
termed total) as an indicator of sequencing depth; this procedure is however 
easily influenced by outliers of read counts at high expression level and DE [18]; 
2) number of reads count in the lower quartiles (a procedure termed quartile), 
which is introduced by baySeq to avoid a possible bias due to outliers [3]; this 
procedure highly depends on sequencing depth that largely impacts quartile 
function; 3) geometric mean of all reads count (called geometric), which is used 
by DESeq [2] and DESeq2 [7] to reduce the influence of outliers on 
approximating the total number of sequence reads; this approach is also 
sensitive to sequencing depth and DE which might alter the total number of 
expressed genes as well as the geometric mean of reads count from all genes 
(see also below data analysis); 4) Trimmed mean of M values (called TMM), 
which is implemented in edgeR and Voom and is based on the assumption that 
the majority of genes with high expression are not DE [18]. In general, all above 
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listed methods rely on the assumption that the majority of genes are equally 
regulated (up and down) or show no change in expression level, while only very 
few genes show true DE. However, this assumption may not apply in many 
situations, for example when gene expression is compared between certain 
tissues or development stages, for which expression of most or at least a large 
number of genes can show dramatic changes. 
Here we introduce a new normalization procedure, termed qtotal, to address 
this problem. It is based on the idea that true DE alters the overall reads count 
distribution (either more or less dispersed), which is reflected by a change in 
the coefficient of variation (CV) between samples, while variation in sequencing 
depth does not affect the CV. qtotal quantifies differences in CV between 
samples and then uses this information to adjust sequence library size, thus 
explicitly taking into account that there is variation in overall DE between 
samples (see Methods for details). We used data sets from SEQC, ABRF, and 
MAQC-II to illustrate the potential problems of different normalization 
procedures (See Datasets for details). These data sets are based on replicated 
RNA samples of the human whole body (UHR) and brain (BHR) [27, 28] and 
show different sequencing depths (ABRF>SEQC>MAQC-II, Table 1). They 
include validated DE genes by quantitative real-time PCR (qRT-PCR) [29] using 
commercially available PrimePCR methodologies from SEQC, which covers 
more than 20,000 genes [17]. We used the PrimePCR results to define 
upregulated DE genes (log2 fold change >0.5, true positives) and 
downregulated DE genes (log2 fold change <0.2, false positives).The three 
data sets show large differences in the number of DE genes of more than  70% 
(Table 1). Moreover, the BHR data set has a larger number of down-regulated 
genes than the UHR data set (60% of DE belongs to down-regulation according 
to the PrimePCR data set under log2 fold change cutoff of 0.5) [13, 17, 21]. 
The normalization procedures affect the discriminative power of subsequent DE 
inference. This influence can be assessed with the help of the true and false 
positive rates (TPR and FPR, respectively) and the area under Receiver 
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Operating Characteristic (ROC) curve (AUC). The AUCs were inferred with the 
ROC package in Bioconductor [30], whereby the ROCs were generated based 
on ordinary fold change under each normalization procedure. We use these 
three approaches to evaluate the performance of the normalization procedures 
on the three above listed data sets (Figure 1). The performance of the 
compared methods varies across the three data sets. The discriminative power 
of the quartile method decreases as the sequence depth decreases (Figure 1, 
from left to right). Normalization with total reads number is generally good, 
indicating that it truly reflects the sequence depth in these three data sets. The 
TMM and geometric methods perform worse than the other three methods, 
which might be due to the fact that the majority of genes in the data sets are 
DE, in apparent contradiction to the methods’ underlying assumption. The qtotal 
method produces the highest AUCs on all three data sets (i.e., 0.836, 0.862 
and 0.806 for the ABRF, SEQC and MAQC-II data sets, respectively). qtotal 
performance is not influenced by sequencing depth. These results suggest that 
the qtotal approach is able to normalize RNA-Seq data according to its true 
sequencing depth, facilitating subsequent DE detection. The below application 
of aFold (e.g., for fold change and DE inference) is thus almost always based 
on qtotal normalization unless specified otherwise.  
 
Figure 1. Normalization of RNA-Seq data. ROC analysis using the qRT-PCR 
validated data sets: ABRF, SEQC and MAQC-II. ROC analysis for PrimePCR data sets 
at a qRT-PCR absolute log-ratio (logFC) threshold of 0.5. TPR, true positive rate; FPR, 
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false positive rate. A gene was considered to be not differentially regulated if its logFC 
in the PrimePCR data was less than 0.2. Five normalization procedures are analyzed: 
qtotal, TMM, total, quantile and geometric. ROCs are based on ordinary log fold 
changes. 
Ilustration of aFold with the SEQC and HapMap-CEU data sets 
Ordinary fold change indicates the extent of DE for a specific gene, although it 
is usually not comparable across genes or data sets because of differences in 
variance. To address this problem, the common idea is to shrink fold changes 
according to dispersion of reads count so that the shrinkage is strong if 
dispersion for a certain gene is high. DESeq2 employs an empirical Bayes 
approach to shrink the log fold change according to the mean and dispersion 
of a gene. The Bayes approach relies on two rounds of fitting a generalized 
linear model (GLM) to the data: 1) GLM is fitted on reads count to obtain 
maximum-likelihood estimates (MLEs) for the log fold changes and a zero-
centered normal distribution of MLEs from all genes; 2) a second GLM is fitted 
again on the reads count data using the zero-centered normal distribution as a 
prior. Interestingly, the second GLM, which relies on the zero-centered normal 
distribution of MLEs from all genes, might be influenced by the number of genes 
with significant DE. If the number of DE genes is high, then the inferred normal 
distribution shows a flat structure and thus little moderation of fold-change (see 
below). This could potentially introduce a bias in the obtained fold change 
values. aFold estimates fold change through modelling uncertainty of reads 
count (see Methods section). In contrast to DESeq2, aFold modelling is not 
influenced by differences between treatments and thus variation in the number 
of DE genes. Instead, fold change from aFold is a function of the expression 
level and dispersion of a specific gene. 
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Figure 2. Fold change shrinkage of the aFold and DESeq2 methods. 
Results are based on the SEQC data set. Fold change is studied for two test 
comparisons, generated by randomly combining samples from the SEQC data set (four 
UHR and two BHR). For the first test comparison, samples from identical conditions 
are combined (all UHR), resulting in the absence of true DE (labeled “Without DE; the 
left and middle panels). The second test comparison additionally includes samples 
from a different condition (next to UHR also BHR), yielding a data set with true DE 
(labeled with DE; right panels). Results for DESeq2 and aFold are based on geometric 
and qtotal normalization. 
The differences between DESeq2 and aFold are demonstrated in Figure 2 
based on the SEQC data set and calculation of logCPM with the function from 
the edgeR package [4]. Six samples in total are randomly selected from this 
data set (four from UHR and two from BHR) to define two test comparisons. 
The first of these was set up to contain no significant DE by randomly comparing 
two UHR with two other UHR samples (thus, all data sets coming from identical 
conditions, labeled “Without DE”). This test comparison shows a skewed fold 
change distribution across different expression levels before application of any 
fold shrinkage procedure (left panels of Figure 2). In this case, both DESeq2 
and aFold shrink fold change towards zero according to expression level 
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(dispersion) but the shrinkage is stronger in DESeq2 (Figure2, middle panels). 
For the second test comparison, we introduced significant DE into the first test 
comparison. For this, we combined two of the above used UHR samples and 
compared them with two randomly chosen BHR samples, yielding a large 
number of significant DE (because of the differences in tissues). This UHR-
BHR combination was added to the above used data set without any DE, 
resulting in a data set with about 40 % of DE (See Additional File 1 for details). 
For this test comparison, the DESeq2-based shrinkage procedure leads to 
almost no change in the fold-change distribution, while that by aFold still results 
in similar shrinkage as seen for the first test comparison (Figure 2, right panels). 
This result suggests that fold change moderation by DESeq2 strongly depends 
on the number of truly DE genes in the data set, which influences shape of the 
inferred zero-centered normal distribution. In contrast, moderation of aFold 
appears to be less affected by DE gene numbers but mainly depends on 
expression level and dispersion (gene specific and overall dispersion). 
We next illustrate the aFold approach with the help of HapMap-CEU data set, 
which consists of 41 highly dispersed samples from 17 females and 24 males. 
The results are shown in Figure 3. logCPM is again calculated with the function 
implemented in the edgeR package [4]. Following [24], a sensitivity analysis is 
predicted to find an over-representation of inferred DE genes from the sex 
chromosomes. 
 
Figure 3. Ilustration of the aFold approach with the HapMap-CEU data set. 
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Seven genes on sex chromosomes are marked by red color. (A) Raw fold change 
(without shrinkage). Five genes on sex chromosome are out of y-axis range. (B) Fold 
change values calculated through the aFold approach. All seven genes from sex 
chromosomes show largest fold changes. 
The ordinary fold changes between female and male samples exhibit high 
variability (Figure 3A) due to high dispersion of the HapMap-CEU data. In 
accordance with our previous study [13], seven genes on sex chromosomes 
are truly DE (shown in red points). For these genes, the ordinary fold change 
values are very large, thus five of the calculated values fall outside of the y-axis 
range. Such high ordinary fold changes are often produced by genes with low 
expression level in at least one of the conditions, which often display a high 
degree of variance. In these cases, the high ordinary fold change does not 
necessarily reflect the true DE, but represent an artefact resulting from chance 
effects at very low expression levels. aFold takes read count variation and 
expression levels into fold change calculation and thus reports comparable 
estimates across expression levels. After shrinkage of variance using the 
approach of aFold, fold change values are much smaller and the truly DE genes 
appear more distinct from the remaining genes (Figure 3B). These observations 
may suggest that aFold is able to rank the truly DE before the non-DE genes 
and produce fold change estimations that directly imply DE. 
Table 2. Number of DE genes from sex chromosomes detected by three 
method in the HapMap-CEU data set at a FDR-adjusted p-value of 0.05. 
Method Sex1/Total2
Sex in Top 10 (Rank) 
p-value Fold-change 
aFold 7/7 7 7 
DESeq2 7/10 7 6 
Voom 7/7 7 5 
        Number of genes identified by each methods in sex chromosomes (1) and total (2). 
Statistical assessment of genes with significant DE confirms the above results 
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(Table 2). Under an adjusted p-value cut-off of 0.05, all three considered 
methods (aFold, DESeq2, Voom) identify seven genes on sex chromosomes 
with significant DE. Both Voom and aFold only report genes located on the sex 
chromosomes, while DESeq2 also finds three additional genes from other 
chromosomes. If ranking by p-value, all seven sex chromosome genes are 
within the top 10 DE genes. However, if genes are ranked by fold changes, then 
only aFold is able to find these seven gene within the top 10. These results may 
suggest that fold changes calculated with aFold are more robust than 
conventional moderated fold change calculations (Voom and DESeq2, 
respectively) in ranking truly DE genes. Consideration of statistical significance 
of DE highlights that aFold has similar power than Voom, yet higher specificity 
in comparison to DESeq2. 
 
Discrimination of DE versus non-DE genes on qRT-PCR validated real 
data 
We next evaluate the discriminative power of the three considered methods 
with the help of three additional data sets. In Table 2, we show that aFold is 
more efficient in ranking true DE before non-DEs. However, the few DE genes 
of the HapMap-CEU data set might lack resolution to reliably assess method 
performance. Therefore, we additionally consider data from the ABRF, SEQC 
and MAQC-II studies. 
The considered ABRF data set consists of RNA-Seq data from the same mRNA 
sample generated by three different laboratories [12]. The ABRF data set 
consists of two conditions (mRNA samples from human whole body and brain), 
which are sequenced with three replicates at three labs. Therefore, the ARBF 
data set contains true DE (two conditions) as well as noise (e.g., from library 
preparation and sequencing), which could be used to assess the accuracy of 
DE detection approaches, especially their ability to discriminate between signal 
and noise. Here, we pooled samples for the same condition from three labs into 
one group (i.e. a comparison of 9:9, nine samples for body and nine for brain). 
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Similarly, the SEQC and MAQC-II data sets contain samples from body and 
brain but with different sequence depths and number of replicates (See table 1 
and methods for further details). Thereafter, method performance is assessed 
with TPR and FPR, using ROC curves and resulting AUCs. The AUC has been 
shown repeatedly to be an informative measure of the overall discriminative 
power of a method [31-33]. The results are shown in Figure 4. aFold appears 
to outperform the other two methods, irrespective of ranking criterions (p-value 
or fold change) and sequencing depth of data sets (ABRF>SEQC>MAQC-II). 
Notably, p-value and fold-change for aFold are monotonically correlated (see 
Methods for details), so its ranking is only based on fold change. aFold reaches 
the highest AUC value of 0.860, 0.824 and 0.774 on the ABRF, SEQC and 
MAQC-II, respectively. 
 
Figure 4. ROC analysis using the qRT-PCR validated data sets. TPR and 
FPR are defined as in Figure 1. aFold outperforms DESeq2 and Voom in ranking true 
differential expression at either model-based p-value (denoted by DESeq2 p and Voom 
p), raw fold change (Voom f) or moderated fold change (DESeq2 f). ROC analysis is 
performed on three data sets ABRF, SEQC and MAQC-II. 
Interestingly, ROC analysis suggests that ranking by fold change is more 
powerful than p-values to detect true DE [11-13]. However, fold changes may 
fail to indicate DE in highly dispersed data (usually genes with low expression) 
(i.e., low FPR, at the beginning of the curve on the ABRF data set). Our model 
moderates fold changes with information from expression level and dispersion 
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and might be more powerful to detect and rank DE genes than ordinary fold 
changes and p-values. Noticeably, aFold performs slightly worse than the 
ordinary fold change approach on the SEQC and MAQC-II data set in terms of 
AUCs (0.824 and 0.774 compare to 0.862 and 0.806) but better on the ABRF 
data set (0.860 to 0.836) (Figure 1 and 4). This might be caused by true DE 
genes with high dispersion (result in strong moderation of fold change), which 
could be improved by an increased sequencing depth. In summary, these 
results suggest that fold change from aFold represents a better way to rank 
truly DE genes than the methods based on ordinary fold change, pvalue or a 
combination of both.  
 
Discrimination of DE versus non-DE genes on simulated real data 
The negative binomial (NB) distribution is most commonly used to increase 
reliability of DE detection as RNA-Seq data shows over-dispersed variance [2, 
4, 7, 13]. Here, we evaluate the ability of aFold through ROC analysis on data, 
which was simulated based on the NB distribution, using mean and variances 
from Pickrell’s RNA-Seq dataset [34]. For all simulations, we choose 10% of 
the 12,500 genes to be DE and symmetrically divide them into up- and down-
regulated genes (e.g., 625 up- and 625 down-regulated genes, indicated below 
by super- and subscripts, respectively). We summarize the results using 
boxplots for two different simulation settings, including data sets with various 
replicate sample sizes and, in each case, ten independent repetitions (Figure 
5). 
When applied on the data that is fully overdispersed according to the NB 
distribution (denoted by NB625 625 , Figure 5A), aFold generally yields higher AUCs 
than alternative methods at large sample size and shows a significant 
advantage over DESeq2 (n=5) and Voom (n=10) (Tukey's test, p<0.01). While 
DESeq2 directly employs a NB model to identify DE, its performance improves 
as the sample size increases (Figure 5A). At all three considered sample sizes, 
aFold produces higher AUC values than DESeq2 and Voom, suggesting that 
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aFold fits the NB data at least as well as the models used in the other two 
methods. 
 
Figure 5. AUC comparison on simulated data. Area under the curve (AUC) for 
aFold and two alternative methods under two simulation settings: (A) Negative 
Binomial (NB) distribution and (B) NB distribution with random outliers (R). Each 
boxplot summarizes the AUCs across 10 independently simulated data sets. Asterisk 
indicates a statistically significant difference in AUC between aFold and any of the 
other methods. n indicates the number of considered RNA-Seq replicates, from (2, 5, 
10). Under all conditions, aFold is highly effective in correctly identifying differentially 
expressed genes.  
Since aFold uses sample variance to calculate fold change and identify DEs, 
we next test the influence of outliers that highly impact the sample variance. 
The outliers are introduced into the NB distributed data by multiplying a 
randomly generated factor between 5 and 10 with the read count of all genes 
in all groups obtained through random sampling with a probability of 0.05. The 
resulting data set (denoted R625 625 ) still has 625 up- and 625 down-regulated 
genes, in addition to random outliers. For these simulated data sets, aFold 
demonstrates a significant advantage (Tukey's, p<0.01) at large  sample sizes 
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(n=5 or 10) and even reaches an AUC of 0.9 at n=10 (Figure 5B). This result 
suggests that aFold together with the outlier detection procedure, which we 
already introduced in ABSSeq, is comparatively mildly affected by outliers. 
Interestingly, performance of the alternative methods also shows variation. For 
example, Cook’s distance from DESeq2 requires a high number of replicates to 
improve its performance in presence of outliers. DE detection of Voom, as 
implemented in limma, is based on log-transformation, which is more robust 
against outliers and thus results in higher AUC values than DESeq2. 
Overall, aFold is at least as good as alternative methods in discriminating 
between DE and non-DE genes in the presence of outliers, irrespective of data 
sample size. 
 
Control of false discovery rate and type I error rate 
Another important aim of reliable DE detection is to control the false discovery 
rate (FDR) and minimize the type I error rate (i.e., the null hypothesis is falsely 
rejected) while identifying a large number of DE genes [21, 35]. To assess these 
two aspects, we compare the ability of the alternative approaches to control  
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Figure 6. Comparison of methods using real data sets. (A-E) Analysis results 
based on the ABRF data set. (F) Analysis with the modencodefly data set. True and 
false positives (TPs, FPs) are defined as described for Figure 2 and used to calculate 
the empirical false discovery rate (eFDR) as FPs/(TPs+FPs). (A) Venn diagram of the 
number of DE genes identified by the three methods. Numbers in brackets indicate the 
eFDR. The specific gene sets of aFold alone or DESeq2 and Voom combined are 
indicated by roman numbers I and II, respectively. (B-C) eFDR as a function of different 
cut-offs of either adjusted p-value (B) or fold change (C) for gene sets I (aFold) and II 
(DESeq2 and Voom). The two inlets show the results based on all DE genes (rather 
than the subset of genes). (D) eFDR (left Y axis) and percentage of detected DE genes 
(right Y axis) for different quartiles of the data (X axis). Solid lines indicate eFDR under 
adjusted p-values of 0.05, dashed lines under adjusted p-values of 0.05 and a log fold 
change of at least 0.5. Red, turquois, and magenta are as in B and C. Grey line and 
points show eFDR for all genes (including both DEs and non-DEs). Genes were 
grouped according to expression (q1, q2, q3 and q4 in boxplot). Lines in blue and 
green show percentages of detected true DE genes across quartiles for gene set I and 
II, respectively. (E-F) Type I error rates for the ABRF (E) and modencodefly (F) data 
sets. Type I error rates are calculated via the number of DEs under p-value < 0.05 
divided by the total number of genes. 
FDR and type I error rates, using again the ABRF data set and, additionally, the 
modencodefly data set. Results are summarized in Figure 6. 
We firstly evaluate the three methods using the ABRF data set, based on the 
same structure as above (e.g. results shown in Figure 4). Method performance 
is assessed with the help of empirical FDR (eFDR), which is the ratio between 
the number of true false positives and the sum of true and false positives (total 
number of detected DE genes) (Figure 6A-D). We also investigated the 
influence of expression levels (Figure 6D) and additional cut-offs (Figure 6B-D) 
on eFDR. The three methods identified similar number of DE genes under the 
adjusted p-value of 0.05, whereby Voom reports the largest number (29120), 
followed by DESeq2 (28997) and aFold (28947, Figure 6A). Moreover, when 
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cut-offs for fold change, expression level and adjusted p-value are combined, 
then these three methods report nearly the same number of DE genes, namely 
12970, 14251 and 14250 for aFold, DESeq2 and Voom, respectively (84% 
overall overlap). This result suggests that the above observed differences 
between aFold and the other two methods result from genes with low 
expression level and/or fold change, which is consistent with findings from 
previous studies [11, 13]. As aFold identifies the smallest number of DE genes 
of the three methods, it also produces a lower overall eFDR (0.079) than both 
DESeq2 (0.097) and Voom (0.098). This may indicate that aFold is able to 
control FDR without reducing sensitivity (total number of DE genes). 
Interestingly, the genes commonly identified by the three methods retain an 
eFDR of 0.070 which is closed to the used adjusted p-value cut-off. The 
additional difference in found DE genes may thus be due to model-dependent 
biases, either as a consequence of the normalization or the statistical approach 
implemented. In fact, the eFDRs for the method-specific genes are much higher 
than those for the commonly identified genes. In particular, the genes only 
revealed by aFold (denoted as the gene subset II) have an eFDR of 0.216, 
while those jointly identified by DESeq2 and Voom (denoted as the gene subset 
I) produce an eFDR of 0.535 (Note that other subsets were not considered 
because they included only a small number of genes, which does not permit 
reliable eFDR calculation). The higher eFDR for gene subset I relative to gene 
subset II may suggest a larger bias caused by DESeq2 and Voom. Similar 
results are also observed in the SEQC and MAQC-II data sets (Supp. Figure 
1C and D). Interestingly, when data is normalized by TMM (Voom) or the 
geometric mean approach (DESeq2), both subsets are reduced (Additional file 
2, Supp. Figure 1A and B). At this situation, only few genes are detected 
uniquely by aFold, suggesting that aFold retains higher specificity than 
alternative methods. The subset I is a result of the normalization procedure in 
aFold (qtotal), which retains low eFDR of 0.216 and supports the efficiency of 
qtotal normalization. However, it also suggests that genes in subset I actually 
58 
 
have comparatively low fold changes. These three DE and normalization 
methods yield similar results when applied on a data set that contains a small 
percentage of DE genes (Bottomly, Additional file 2, Supp. Figure 1E, F and G). 
Next, we try to reduce eFDR for these two gene subsets by applying more 
stringent adjusted p-value cut-offs (Figure 6B) or additional fold change cut-offs 
(Figure 6C). Both alternatives can improve the overall eFDR (for the entire set 
of DE genes, inlet figure in Figure 6B and C). However, eFDR for gene set I is 
not reduced through adjusted p-value cut-offs but rather increases with higher 
cut-off values. Fold change together with adjusted p-value can efficiently 
decrease eFDR for subset I to a level of 0.05. On the other hand, both cut-offs 
consistently reduce eFDR of subset II to 0.05 (adjusted p-value =1.0e-9 or 0.05 
with log fold-change = 0.4). These results suggest that high eFDR of subset I 
and II is due to low fold changes (low dispersion). Since false positives often 
result from under-estimation of variances (with low fold change but high 
expression or high fold change but low expression) [11-13], we compared 
eFDRs across different categories of expression level (four quartiles, Figure 
6D). Indeed, many genes from subset I and II come from the 1st (low expression) 
and 4th (high expression) quartile (given in light blue and green in Figure 6D, Y 
axis on the right side of the panel). Generally, eFDRs at 1st and 4th quartile are 
higher than 2nd and 3rd for total (grey line). aFold (red line) shows generally 
lower eFDRs in all quartiles but the 1st one than those obtained for all genes 
(both DE and non-DE genes, grey line in Figure 6D, Y axis on left side), 
whereas DESeq2 (blue line) and Voom (pink line) show a similar pattern than 
that found for all genes. This observation may suggest that aFold is able to 
improve eFDR at most of expression levels.  
Then an additional fold change cut-off of 0.5 is used (under log2-tranformation), 
then eFDR reduces to around 0.05 in all quartiles for aFold but only the upper 
ones (3rd and 4th) for DESeq2 and Voom, which produce no change at 1st 
quartile (0.164 to 0.164) and only a slight improvement at 2nd quartile (0.075 to 
0.067). In fact, reducing eFDR for DESeq2 and Voom in 1st quartile to a similar 
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value of 0.05 requires an extremely high log fold change cut-off of 4.0. Such a 
cut-off additionally decreases the total number of DE genes to 3564 and 3224 
for DESeq2 and Voom, respectively. At the same time, applying a log fold 
change cut-off of 0.5 for aFold still yields a total of 15325 DE genes. A more 
efficient way to reduce eFDR at 1st quartile for DESeq2 and Voom is to use a 
combination of cut-offs for expression level and also p-value (eFDR=0 under 
logCPM>0 & adjusted p-value <0.05). These results suggest that aFold is able 
to control FDR by reducing false positives at all expression level while retaining 
sensitivity, even when more stringent cut-offs are used. 
We next compare the methods in their ability to control type I error rates (i.e., 
the null hypothesis is falsely rejected and thus result in false positives). We use 
two gene expression data sets: 1) the ABRF data set as above, including data 
from the same RNA sample but generated by three different laboratories sites, 
each with 3 replicates; and 2) the modencodefly data set, which contains data 
for development processes of the fruitfly Drosophila melanogaster [36], with 
technical replicates ranging from 4 to 6. For the modencodefly data set, we 
randomly selected 4 replicates for each condition and separated them into two 
groups, which should thus only be characterized by stochastic variations but 
not true DE. The results of our analysis is summarized in Figure 6E (ABRF) and 
6F (modencodefly). At the p-value cut-off of 0.05, only aFold is able to control 
the type I error rate around 0.05 for the ABRF data set while the other two 
methods produce a rate above 0.2. For the modencodefly data set, all three 
methods are able to control type I error rate around 0.05, but aFold reports the 
smallest number of false positives (average of 14), followed by DESeq2 (119) 
and Voom (867). Thus, for both data sets, aFold reduces the type I error rate to 
a larger extent than the alternative methods (Wilcoxon rank test, p<0.1), 
consistent with above results for eFDR. 
Taken together, the approach implemented in aFold is able to control FDR and 
type I error rates more efficiently than the two tested alternative approaches. 
Moreover, p-values inferred from aFold are directly deduced from and thus 
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monotonically correlated with fold-change, which allows to apply single cut-off 
values to select candidate DE genes for further analysis. More importantly, 
aFold also takes into consideration uneven dispersion across expression levels, 
which avoids possible biases in inferred DE genes due to large fold change at 
low expression level [13] and thus permits comparable analysis of DE across 
different types of data distributions (and thus gene expression characteristics). 
 
Improved visualization of RNA-Seq data 
The results of transcriptomic studies are often visualized using a heatmap, 
which usually takes log fold change as input [37, 38]. However, ordinary fold 
change ignores sample variance and might result in contradictory patterns in 
the obtained graphical visualization (e.g., a gene may be upregulated in one  
 
Figure 7. aFold improves visualization of RNA-Seq data. Heatmap of DEs 
from the same condition but different lab sites that only show significance in one of the 
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lab sites (based on the ABRF data set). Numbers below heatmaps indicate the total 
number of genes included. Scatter plots show log fold change distribution across 
expression levels in each heat map. L, R and V stand for lab sites. 
but downregulated in another replicate of the same experiment). aFold takes 
the observed and mean related variance into account during fold change 
calculation and, thus, it produces more consistent fold change measures across 
groups. Here we used the ABRF data set to demonstrate how aFold improves 
the visualization of RNA-Seq data. The ABRF data sets consist of RNA-Seq 
data from the same RNA samples, measured under two conditions, but 
processed and analyzed by three different laboratories. The inferred DE 
variation among lab sites should only result from random or batch effects 
(unwanted) environmental or procedural variations, for example due to some 
differences during library preparation and/or sequencing error. The analysis 
results indeed identifies a high overlap across lab sites of more than 80% for 
DE genes detected by the three methods.  
However, there are still unique genes identified at each lab site for each method, 
which are most likely caused by variance under-estimation due to limited 
sample size (n=3). We take genes that show significance at one lab site from 
each method as unique genes for each method (adjusted p-value < 0.05), as 
illustrated in Figure 7. aFold identifies the smallest number of genes with unique 
DE (most of them retain log fold change <0.5) at only one site but similar pattern 
across three lab sites (all are up or down-regulation). In contrast, DESeq2 and 
Voom report many genes that show opposite regulation patterns with high fold 
change (log fold change >1), which are likely caused by high dispersion across 
samples and lab sites.  
Fold change measures reported by DESeq2 and Voom are unable to capture 
the magnitude of expression differences and therefore might result in unreal 
opposite regulation pattern. Indeed, over 75% of genes in each unique set show 
very low expression (logCPM < 0). These genes also often exhibit high variance 
combined with high fold change (Figure 7, scatter plot) [2, 8, 13], thus requiring 
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shrinkage of fold change or additional filtering of expression level to reduce 
false positives [9, 11-13]. The difficulty here is that there is no universal cut-off 
value for expression levels because reliability additionally depends on sample 
size (e.g., large sample size can enhance reliable variance estimation in highly 
dispersed data and thus also reduces error rates). Here, we demonstrate that 
aFold is able to accurately estimate fold change by taking into account variance. 
Thus, aFold improves the visualization of expression data by reducing DE 
variation, which in turn will facilitate pattern discovery (clustering) and gene set 
enrichment analyses [38]. 
 
Conclusions 
Here we first introduce a new normalization procedure, qtotal, which adjusts for 
the influence of the number of DE genes on the overall reads count distribution 
and accurately approximates the true sequence depth. qtotal is highly 
compatible with sequence library size and DE when applied on real data set 
and thus might help standardization of RNA-Seq data and downstream 
analyses. In addition to qtotal, we also present a new method, aFold, for fold 
change estimation and differential expression analysis of RNA-Seq data. 
Distinct from other current methods, aFold produces fold changes which take 
into account observed variance and mean-related variance. It thus permits 
reliable fold-change comparisons across genes, which will help ranking of 
genes or isoforms for selection of candidates for subsequent analysis and gene 
set enrichment analysis [38]. Using real and simulated data sets, we 
demonstrate that aFold is capable of discriminating DE and non-DE. We also 
introduce a statistical framework based on aFold to infer statistically significant 
DE genes. This approach shows high power to control FDR and type I error 
rate across expression levels. In consideration of variance from all sources, 
aFold produces consistent fold change measures across experiments and 
might facilitate data clustering and visualization. Based on our analysis, we 
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conclude that aFold represents a highly efficient novel approach for fold change 
estimation and identification of significant DE across a wide range of conditions. 
It may help the experimentalist to avoid an arbitrary choice of cut-off thresholds 
and may enhance subsequent downstream functional analyses.  
 
MATERIALS AND METHODS 
Datasets 
Results of this study are based on two types of data sets: simulated and real 
data. The simulated data sets are derived from the study of Soneson et al. [10], 
which simulated read count for 12,500 genes from a NB distribution with mean 
and variances from Pickrell’s RNA-Seq dataset [34]. Pickrell’s data set consists 
69 lymphoblastoid human cell lines derived from unrelated Nigerian individuals. 
The simulated data is generated under two conditions: NB and NB with random 
outliers (denoted by R). Each set includes 10 independently repeated 
simulations of two treatment groups and different replicate sample sizes of 2, 5 
or 10 for each group. 
In addition, seven real data sets were used to assess the performance of DE 
inference methods (Table 1). The first four data sets are based on replicated 
RNA samples of the human whole body (UHR) and brain (BHR) [27, 28]: ABRF, 
MAQC-II, SEQC and PrimePCR (qRT-PCR validated data set to define true 
DE). The ABRF data set refers to the Association of Biomolecular Resource 
Facilities next-generation sequencing (ABRF-NGS) study, which assessed 
RNA-Seq data variation across laboratory sites and platforms [12] . Here we 
use data from two samples generated via a ribo-depleted protocol, namely RNA 
from cancer cell lines and also RNA from pooled normal human brain tissues. 
We thus exclude data from mixtures of these samples and that based on other 
protocols. The raw data and counts tables are available at the Gene Expression 
Omnibus database under accession number GSE48035. The considered RNA-
Seq data compares two conditions (UHR and BHR), whereby the same RNA 
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samples are analyzed in three different laboratories. Any variation between 
these laboratories should not be due relevant biological differences, but result 
from variations across sites in environmental and also procedural factors. The 
MAQC-II data set consists of seven replicates for each condition and is 
generated by the MicroArray Quality Control (MAQC) study to evaluate the 
performance of different gene expression analysis methods [39]. The raw data 
of MAQC-II are available from the NCBI SRA database under SRA010153 and 
counts table is downloaded from http://bowtie-bio.sourceforge.net/recount/ [40]. 
The SEQC data set consists of five replicates and is generated by Sequencing 
Quality Control (SEQC) study [17] available under GSE49712. The PrimePCR 
data set is based on the PrimePCR approach of qRT-PCR and includes more 
than 20,000 validated DE genes from SEQC (MAQC III), available under 
GSE56457. 
Three additional real data sets were downloaded from http://bowtie-
bio.sourceforge.net/recount/ [40]. The first of these is the modencodefly data 
set from the modENCODE project [41], which assesses gene expression during 
the development of Drosophila melanogaster [36], covering 30 distinct 
developmental stages. Each of the stages consists of 4 up to 6 technical 
replicates, which provides an opportunity to construct subgroups per 
developmental stage to study stochastic variations but not true DE. We 
accordingly subsample from each stage to construct a 2:2 pairwise study. 
The next real data set is the HapMap-CEU data set [42], which includes 41 
samples based on immortalized B-cells from 41 unrelated CEPH grandparents. 
It contains a relatively large sample size (17 female samples and 24 male 
samples) and high variations in read count due to genetic diversity. It is well-
studied and useful for measuring the ability of DE detection models on large 
samples and variations [7, 8, 13]. 
We also considered the Bottomly data set, which is from a study that 
characterized transcriptomic differences between two inbred mouse strains 
(C57BL/6J and DBA/2J) with 10 and 11 replicates each, respectively [43]. We 
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filtered out genes with zero read counts across samples before analysis. 
The basic statistics for all real data sets are summarized in Table 1, including 
the average total number of reads count, the number of present genes, sample 
size and the average number of DE genes. 
Table 1. Overiew of the used real data sets. 
Set name 
Average 
library size
#Present 
Genes 
Sample 
size 
#DEs1 Used for 
ABRF 82297717 35647 18 28996 
DE & Type I 
error 
SEQC 57635606 20821 10 17054 DE 
MAQC-II 1421992 11907 14 8386 DE 
Modencodefly 13709954 13244 147 - Type I error 
HapMap-CEU 5187226 12410 41 8 DE 
Bottomly 4904164 13932 21 1119 DE 
PrimePCR - 20801 - 16603 True DE 
(-) indicates that the statistics are not applied. (1) the number of DEs represents average 
DEs reported by aFold, DESeq2 and Voom. 
Normalization and outlier detection 
Reads count of RNA-Seq data requires normalization before DE inference in 
order to reduce possible biases from sequence depth, library preparation or 
even analysis in sequencing lanes [18, 26]. Current approaches for 
normalization rely on the assumption that the majority of genes (or at least 
those with high expression) are not DE. This assumption might not be valid 
under certain biological processes, such as development or aging, when gene 
expression shows dramatic biological variation. In contrast to current 
normalization approaches, we assess the overall data dispersion between 
samples and then use it to adjust normalization. The ratio of library size 
between two samples can be represented as  
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where ||A Bn  and ||A B  stands for the number of present genes (i.e., genes that 
show expression in samples A or B) and expected reads count per gene in the 
sample A and B, respectively. An  and Bn  are usually assumed to be identical 
in current approaches. However, the total number of present genes can vary 
due to DE and thus the ratio between An  and Bn  needs to be estimated from 
the data. According to G.4.2 in [44], the effective degree of freedom (effective 
sample size) is inversely proportional to the CV. As a result, the ration of An  
and Bn  can be approximated as 
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where ||A Bcv  are the CVs for reads count in the sample A and B, respectively. 
The ratio between A  and B  can be estimated from the observed average 
reads count in each sample as  
 0 A A
B B
r       (3) 
While the genes with high expression show low dispersion [7, 8], an estimation 
of 0r  on genes with high expression should be more stable. However, due to 
DE, the order of genes according to expression is not identical across samples 
and ranking via A or B will report different group of genes with high expression 
as well as 0r . Here we choose the sample that shows small overall CV to rank 
the genes because the sample with smaller overall CV is less likely influenced 
by extreme values of reads count (outliers). In addition, since the larger overall 
CV in a sample indicates stronger up-regulation of genes (increased dispersion) 
in this sample, ranking via this sample will move the genes with stronger up-
regulation towards the right tail (high expression), which in turn enlarges the 
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estimation of or . After ranking, the or  is then obtained via sliding windows, that 
is 
 , |,
, |
| 1
   rank by    
| 1
cvA k window A
j o cv
cvB k window B
A r cvr r
B r cv


  
  (4) 
where j is the index of the sliding window. ,j or  might be influenced by outliers 
which could result in abnormal , 1,/j o j or r  . We then trim ,j or  based on , 1,/j o j or r   
via median absolute deviation (MAD) and keep the ,j or  with the largest k as 
observed ratio or . The trimming is also applied on (2). The actual ratio is then 
calculated from (1). In practice, we select one sample (default is the one with 
the largest number of reads count) as control and then apply this procedure on 
all samples to obtain the size factor for normalization. This procedure is 
implemented as qtotal in ABSSeq  and set as default normalization procedure 
for aFold. 
For the other two methods, we used the default normalization procedures 
(voom and TMM for Voom, geometry mean for DESeq2). Outliers influence DE 
detection through shifting both mean and variance [7, 13], which thus needs to 
be corrected for. Here we integrate the procedure from our previous ABSSeq 
approach into aFold, which utilizes the median absolute deviation (MAD) to 
detect the outliers in log-transformed read count and shrink the read count of 
outliers toward median of read count from one condition.  
 
Moderating uncertainty of read count 
Due to biological and/or other sources of variance, the observed expression 
value for the ith gene ig  is given as the mean i   with uncertainty  i . 
 i i ic      (5) 
In practice, the uncertainty is represented as the standard deviation (SD) of 
samples if the SD is independent of the mean. However, In RNA-Seq data or 
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microarray data, the SD is not independent of i  and could be generally 
written as 
   0i i i ia a     (6) 
This implies that there is propagation of error (uncertainty) in measurement of 
SD based on i . Therefore, an accurate reads uncertainty measurement 
should also include the propagation of error from (6). In theory, the propagation 
uncertainty of SD could be written as 
 , ( )i s i i i ia SD g a s     (7) 
where is  is the sample SD of ig . Thus, the uncertainty of reads counts for 
each gene becomes 
 ,i i i s i i is s a s       (8) 
ia  in (2) actually serves as the CV as 
 i ii
i i
sa       (9) 
Simply, the uncertainty of ig  becomes a polynomial function of sample SD is  
 
2
i
i i
i
ss     (10) 
In addition to the observed variance, there are still hidden variances upon 
expression levels, which are usually described as  
 2i i    (11) 
which is dominated by mean read counts of each gene [7]. As a result, the 
uncertainty from expression level becomes 
 iˆ i i      (12) 
We leave out the second term of the polynomial function of (10) in (12) because 
i  is the expected SD for each gene and contains no propagation error. iˆ  
actually sums up uncertainty across samples and thus requires moderation of 
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the sample size as 
 ˆ i ii
i im m
     (13) 
where im  is defined as the effective sample size for each gene. We use the 
effective sample size instead of the real sample size in (13) to capture the data 
structure (i.e, overal dispersion of CVs). According to G.4.2 in [44], a global 
effective sample size (effective degrees of freedom) can be obtained via 
 
2( )   
var( )
i i
i
i i i
mean v sm v
v       (14) 
Instead of using original CVs, m is calculated from moderating CVs, which 
retains information of uncertainty of i  and is more stable (Figure 8A), thus 
avoiding under-estimation of m. The effective sample size im  actually varies 
across expression levels since the biological variation is more difficult to capture 
at low than high expression levels. We thus assume that the genes with highest 
expression  retain m  as im  and the rest of genes have a decreasing im  as 
 
2
0
0 02 ( )  max( , min )( )i i
i
i
i i
kvm v v
v
v f v      (15) 
where iv  is the smoothed CV by the locfit package from R [45] and 0v  is prior 
value that could be provided by users to avoid over-estimation of im  (default 
is 0.05). We use 2 20/iv v  instead of 0/iv v  because k is proportional to 
2
iv  as 
in (15). The final uncertainty is then called as 
 ˆ ii i i i
im
         (16) 
 
Moderating fold change by uncertainty of read count 
In our previous study [13], we show that the log fold change can be described 
as  
70 
 
 log( )  max( , ) | |ii i iA iB i iA iB
i i
clfc c
c
          (17) 
This relationship specifies that log fold change depends on the expression level 
and the mean read count difference between two conditions (denoted as A and 
B). Under (17), same mean difference refers to larger log fold change at lower 
expression level. However, a large uncertainty for i  may imply that the actual 
expression level of ith gene is higher than i  and, thus, the uncertainty could 
be treated as unobserved read count. The actual or robust fold change can then 
be written as 
 
ˆ ˆlog( )  
ˆ
i
i i i i
i i
clfc c c
c
     (18) 
The fold change is thus shrunk toward 0 according to uncertainty or variance.  
 
Figure 8. aFold modeling. Illustration based on the HapMap-CEU (A-B, large 
sample size n=24), Modencodefly (small sample size n=2, C) and ABRF (middle 
sample size n=9, D) data sets. (A,C-D) Mean-variance modeling and coefficient of 
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variation (CV) normalization. Grey horizontal line indicates the baseline of CV. Red 
points in the inlet show CVs after uncertainty transformation. Red line (main panel) and 
black line (inlet) represent the fitted value of CV via locfit. (B) Distribution of aFold. Red 
line indicates a zero-centered normal distribution with an estimated standard deviation 
(SD) of 0.089. 
As a result, the fold change from (18) presents a robust way of measuring 
differential expression since it fully accounts for the mean and variance of 
expression values. We thus term this procedure accurate fold change (aFold) 
approach. 
Determination of the cut-off of aFold  
While the ordinary log fold changes usually follows a normal distribution with 
zero mean [7, 9, 46], aFold also has a zero-centered normal distribution (Figure 
8B, HapMap-CEU). Therefore, the cut-off (significance threshold) of aFold can 
be determined by estimating the SD of the zero-centered normal distribution. 
Notably, the aFold calculation approach is equivalent to adding the 
pseudocounts ( i ) to read count. This has no influence on read count variance, 
but stabilizes the CV (variance stabilization, inlets in Figure 8A, 8C and 8D). 
Based on this procedure (i.e., adding i ), we obtain for each data set a general 
CV for the count level or SD for log transformation of counts (also as the SD for 
aFold). We can next calculate the general SD under log transformation via 
moments estimation as 
 log( ) / 1mean s n     (19) 
  from (19) well fits the distribution of aFold (Figure 8B, red line). Then the p-
value of each aFold is generated via the normal distribution as 
 ( ,0, )ip pnorm lfc    (20) 
After an adjustment of multiple testing (i.e, Benjamini-Hochberg in default), a 
data-specific aFold cut-off is obtained in consideration of the significance level. 
Implementation 
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aFold has been implemented and integrated in the software package ABSSeq 
for the cross-platform environment R [47]. aFold is released under the GPL-3 
license as part of the Bioconductor project [30] at URL: http:// 
bioconductor.org/packages/devel/bioc/html/ABSSeq.html. 
 
Software tools 
The figures in this study have been plotted using R. 
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Additional file 1: Supplementary Methods. Overview and command lines for 
differential expression analysis in R. 
R commands 
Here, we list the R commands for each method  that were used to analyze the 
data in this study. As explained in the main text, we run each method in default 
settings. All analyses were performed with R version 3.4.0. The data matrix and 
conditions are denoted as cdat and cgroup, respectively. In addition, we list the 
function for data mixture in Figure 2. 
ABSSeq-aFold 
aFold is integrated into the ABSSeq package, version 1.22.2, which is available 
in Bioconductor. 
>  library(ABSSeq) 
>  obj  <- ABSDataSet( cdat, cgroup ) 
>  obj <- ABSSeq(obj, useaFold=TRUE) 
> res <- results(obj, c("Amean","Bmean","foldChange","pvalue","adj.pvalue")) 
 
DESeq2 
The DESeq2 package, version 1.16.0, can be obtained from Bioconductor. 
>  library(DESeq2) 
>  ds <- DESeqDataSetFromMatrix(countData = cdat, colData = data.frame(cgroup), design = 
+                                                         ~ cgroup) 
>  ds <- DESeq(ds) 
>  res <- results(ds) 
 
limma-Voom 
The limma package, version 3.32.0, can be obtained from Bioconductor.  
>  library(limma) 
>  library(edgeR) 
>  design <- model.matrix(~0+cgroup) 
>  colnames(design) <- levels(cgroup) 
>  nf <- calcNormFactors(cdat) 
>  dat <- voom(cdat, design, plot=FALSE, lib.size=colSums(cdat) * nf)  
>  fit <- lmFit(dat,design) 
>  contrast.matrix <- makeContrasts("condB - condA", levels=design) 
>  fit2 <- contrasts.fit(fit, contrast.matrix)  
>  fit2 <- eBayes(fit2) 
>  res=decideTests(fit2,p.value=q.cut,lfc=lfc) 
>  tab<-topTable(fit2, adjust = "BH", number=nrow(fit2), sort.by='logFC') 
 
Mix of data 
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>  mixData=function(UHR,BHR,normmethod) 
>  { 
>  sizefactor<-normmethod(cbind(UHR[,3:4],BHR[,3:4])) 
>  dsize <-sizefactor[1:2]/sizefactor[3:4] 
>  dout <- t(t(BHR[,3:4])*dsize) 
>  rout <- round(dout)  
>  dif <- dout -rout 
>  rout[dif>0.5] <- rout[dif>0.5]+1 
>  out <-rbind(as.matrix(UHR),as.matrix(rout)) 
>  rownames(out)=1:nrow(out) 
>  return(out) 
>  } 
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Additional file 2: Supplementary Figure. Venn diagrams show number of DE 
identified by aFold, DESeq2 and Voom on four data sets. 
 
Supp. Figure 1. Venn diagram. Venn diagrams show number of DE identified by 
aFold, DESeq2 and Voom on four data sets: (A-B) the ABRF data set; (C) the SEQC 
data set; (D) the MAQC-II data set; (E-G) the Bottomly data set. aFold detects DE 
under three normalization procedures: qtotal (C-E), TMM (A and F) and geometric 
mean (B and G). Numbers in brackets indicate the eFDR. 
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Supplementary files S2: Manual for WormExp 
   
83 
 
84 
 
85 
 
86 
 
 
Note: the supplementary tables are too large to be attached here and they are 
available at https://doi.org/10.1093/bioinformatics/btv667  
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Note: the supplementary tables are too large to be attached here and they are 
available at http://doi:10.1016/j.dci.2015.02.010   
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Additional file 1: Illustration of the lawn leaving assay. 10 hermaphrodites at 
the L4 stage were transferred by picking onto 9 cm peptone free NGM plates 
containing a lawn of the tested bacteria, each mixed with E. coli OP50 and surrounded 
by a ring of 80 μl of OP50. 
 
 
Additional file 5: Figure on the leaving phenotypes of the introgression 
lines (ILs) plotted against the introgression position along the 
chromosomes. (A) Results for E. coli strain OP50; (B) non-nematocidal B. 
thuringiensis strain DSM350; (C) nematocidal B. thuringiensis B-18247; and (D) highly 
nematocidal B. thuringiensis B-18679. Green and red lines show the results after either 
14 h or 24 h exposure, respectively. Position of markers is given along the X axis. Light 
gray vertical lines indicate boundaries of the chromosomes.  
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Additional file 9: Figure on the separate analysis of N2 and CB4856 
survival in the presence of nematocidal B. thuringiensis. (A) Survival on B. 
thuringiensis strain B-18247; and (B) B-18679. Survival on the Y axis is plotted against 
BT concentration on the X axis. Error bars represent standard error of the means.  
 
 
Additional file 10: Figure on the separate analysis of lawn leaving 
behavior of N2 and CB4856 towards E. coli and P. aeruginosa. (A) Results 
for avoidance of E. coli strain OP50; and (B) P. aeruginosa strain PA14. The asterisk 
(*) points to a significant difference to N2. The dotted reference line indicates the 0.5 
avoidance response. 
 
Note: the additional tables are too large to be attached here and they are 
available at https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-
016-2603-8 
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Note: the supplementary tables are too large to be attached here and they are 
available at https://doi.org/10.1016/j.zool.2016.05.013 
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Discussion 
Omics data requires efficient statistical tools to reduce noise and explore the 
underlying biological functions. In my PhD project I mainly focused on the 
analysis of transcriptome studies in C. elegans. This work describes the 
development of new approaches for the analysis of this type of data (Chapter 
I-III), including the inference of underlying biological function (specifically 
focused on the case study of the innate immune system, Chapter IV-VII). This 
discussion is separated as three parts: i) DE detection of RNA-Seq; ii) meta-
analysis for biological function inference, namely gene set enrichment analysis; 
iii) innate immunity of C. elegans. 
1. RNA-Seq analysis 
RNA-Seq is widely used to study gene expression and inducible responses of 
model and non-model organisms [1]. The usage of RNA-Seq data requires 
normalization in order to reduce possible sequencing and biological biases [2, 
3]. We propose a new normalization procedure called qtotal, which facilities 
comparison of gene expression across samples via taking into account the 
overall distribution of reads count per sample (Chapter II). Additional 
information (e.g, gene length and GC content) might also influence the reads 
distribution and need to be accommodated in next version [4].  
The commonest aim of RNA-Seq studies is to understand inducible biological 
functions through an analysis of differential gene expression (DE). We show 
that DE inference should not only rely on fitting the distribution of read counts 
with probabilistic models, but also on measuring the magnitude of expression 
difference by absolute counts difference (Chapter I) or fold change (Chapter II). 
As we show in Chapters I and II, the main question of DE inference for RNA-
Seq is to handle the estimation of variance from samples with limited size. 
Despite the improvements that we proposed, identifying DE at low expression 
level is a remaining open question, which might be not able to be solved by 
statistical models and requires specific improvement of RNA-Seq (e.g, targeted 
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RNA sequencing [5]). Moreover, ABSSeq (Chapter I) and aFold (Chapter II) is 
currently designed for pairwise comparison, which lacks the ability to handle 
complex experimental set-up (e.g., time series and multiple treatment) and 
needs to be extended in future.  
2. Meta-analysis 
High-throughput molecular technologies usually yield hundreds or thousands 
of differentially regulated genes or proteins that are not always easy to interpret. 
Uncovering the underlying organizational principles from such large gene lists 
requires meta-analysis. We constructed a taxon-specific database by collecting 
curated high throughput data sets of C. elegans, which help interpret new data 
and uncover underlying biological mechanisms (Chapter III-VII). However, large 
number of datasets retain redundant information (overlapping with each other) 
and result in amounts of significances in meta-analysis, which are not easy to 
interpret. To reduce or summarize the obtained results, an advanced or 
complex model might be helpful. For instance, a model with Bayesian network 
will uncover the causality across data sets [6]. Identifying common regulatory 
elements for the data sets may be also useful to interpret the overlapping and 
summarize the results from meta-analysis. 
3. Innate immunity of C. elegans 
The immune system that maintains organismal homeostasis and responds 
against microbe offenses is traditionally divided into two types: innate immunity, 
which serves as general defense and adaptive immunity that is characterized 
by the ability to mount specific immune responses according to the pathogen 
[7]. The nematode C. elegans only relies on the innate immune system, which 
is mainly conserved across animals [8]. Immune response to pathogens reflects 
as altering gene expression profiling via triggering immune signaling pathway 
(namely immune related genes). Interestingly, while immune related genes in 
C. elegans to various pathogens are diversity, the promoter of these genes 
share a common regulator element: the GATAA transcription factor (TF) motif 
(Chapter VI). It suggests that the conserved immune pathways of C. elegans 
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might crosslink through GATAA bound TFs. However, there are 12 known 
GATAA-bound TFs (e.g., six members of elt family) in C. elegans according to 
Wormbase [9], which function in different tissues and might play a specific role 
in responding to various pathogens. Interestingly, our study shows that the gene 
npr-1 in C. elegans exhibits specificity in defense against two pathogens: P. 
aeruginosa strain PA14 and B. thuringiensis strain B-18247, suggesting that the 
innate immune system is also capable of specific responses to pathogens via 
regulating different sets of genes (Chapter V). In fact, these two pathogens 
trigger distinct gene expression changes in C. elegans, which could be both 
suppressed by npr-1 knockout. This indicates that npr-1 might be involved in 
different pathways that specifically defend against these two pathogens and 
could be an interesting topic for a potential future study. 
In addition to conserved immune pathways across animals, C. elegans also 
expresses diverse antimicrobial peptides, which have a function in the 
elimination of pathogens (Chapter VII). The mechanisms by which antimicrobial 
peptides are activated to clear pathogens rely on signaling pathways which are 
not yet to be uncovered. Moreover, antimicrobial peptides potentially display 
high redundancy through multigene families, which hinders the investigation of 
their roles in immune response. Uncovering the mechanism of antimicrobial 
peptides in elimination of pathogens requires a high throughput survey assay 
and/or meta-analysis of large data sets. Moreover, the immune response might 
differ at transcript level and protein level (Chapter IV), suggesting that 
hierarchical information is required for understanding and identifying these 
immune effectors. Furthermore, a complete omics study of immune response 
including data at transcript level, protein level and metabolism level might reveal 
new insights into host-pathogen interaction as we have shown for B. 
thuringiensis and C. elegans (i.e., linkage between damage and insulin like 
signaling pathway via AMPK, Chapter IV). 
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